From cells to organoids: Cytokines that shape 3D culture

Introduction
Organoids are three-dimensional, self-organizing models derived from stem cells that recapitulate key structural and functional features of in vivo tissues. Cytokines and growth factors provide essential niche signals that regulate stem cell proliferation, self-renewal, and differentiation¹^, ². Classical factors such as R-spondin 1 (RSPO1), EGF, Noggin and Wnt3a, together with tissue-specific and emerging signals such as FGFs, NRG1, and IGF2, support organoid establishment, expansion, and differentiation³^, ⁴. With growing applications in disease modeling, drug screening, and precision medicine, reliable cytokines are increasingly important for reproducible organoid culture⁴. Sino Biological provides high-quality cytokines with validated bioactivity and consistent performance to support diverse organoid culture and research applications.

Cytokine Signaling in Organoid Culture
Organoid culture depends on the reconstruction of signaling environments that normally govern cell fate within tissues. Rather than acting independently, cytokines and growth factors form interconnected signaling networks that balance stem cell maintenance, proliferation, and differentiation. A classic example is the WENR system, in which Wnt3a and RSPO1 reinforce Wnt/β-catenin signaling, EGF promotes epithelial proliferation, and Noggin suppresses BMP signaling to help maintain the stem/progenitor state⁵^, ⁶. Beyond this core framework, tissue- and stage-specific signals further shape lineage commitment, maturation, and cellular composition. Recent organoid systems increasingly incorporate additional FGF, TGF-β/BMP, Notch, and other pathways to reproduce more complex tissue patterning and cellular interactions⁷. The composition and timing of these signals can therefore profoundly influence organoid identity and phenotype, enabling the development of models that more closely reflect the biology of their tissues of origin.

Figure 1. Key signaling pathways and representative cytokines and growth factors involved in organoid development. Tissue-specific combinations of cytokines and growth factors regulate major signaling pathways, including FGF, WNT, BMP, and NOTCH signaling, to guide lineage commitment and the development of brain, retinal, lung, cardiac, liver, kidney, and vascular organoids. Representative factors commonly used in these culture systems are shown.

From Cytokine-Guided Culture to Translational Applications
The ability to precisely control cytokine and growth factor signaling has expanded organoids from experimental 3D cultures into increasingly relevant models for translational research. Defined culture conditions support the establishment and expansion of tissue- and patient-derived organoids while helping preserve key cellular, molecular, and functional features of their tissues of origin⁸^, ⁹. These models provide biologically relevant platforms for disease modeling, drug efficacy and toxicity testing, and preclinical therapeutic development⁸. Patient-derived organoids further capture inter-patient heterogeneity and can be used to evaluate individualized treatment responses, supporting their growing potential in precision medicine⁹^, ¹⁰. Importantly, reproducible cytokine and growth factor conditions are essential for generating consistent organoid phenotypes and reliable downstream readouts¹¹.
Table 1. Translational Applications of Cytokine-Guided Organoid Models

Applications in Research
Recombinant growth factors are widely used to establish and maintain organoid models across different tissue types. For example, EGF and bFGF have been incorporated into culture systems for the generation of mouse pancreatic ductal organoids (Figure 2), providing an ex vivo model for studying pancreatic epithelial biology. Similarly, R-Spondin has been used as a key component of mouse colonic organoid culture, supporting the transition from isolated colonic crypts to established organoids (Figure 2). These examples illustrate how defined growth factors can support organoid-based studies across diverse tissue models.

Figure 2. Application of recombinant growth factors in pancreatic ductal organoid culture. Representative bright-field images of mouse pancreatic ductal organoids cultured under Org and 4F conditions. Recombinant murine EGF and human bFGF from Sino Biological were included in the 4F culture medium to support pancreatic ductal organoid generation.
Source: doi: 10.3724/abbs.2024218

Figure 3. Application of R-Spondin in mouse colonic organoid culture. Representative images showing(A) freshly isolated mouse colonic crypts and (B) colonic organoids after 5 days of culture R-Spondin (cat# 11083-HNAS) was included as a component of the organoid culture medium.
Source: doi: 10.1093/carcin/bgt412

Sino Biological Solutions for Organoid Research
Sino Biological provides a comprehensive portfolio of cytokines and growth factors to support organoid establishment, expansion, differentiation, and functional research across diverse organoid models. Its organoid research solutions cover 3D organoid culture, physiological organoids, and tumor organoids, providing researchers with relevant signaling factors for different tissue types, culture stages, and research applications.

Table 2. Featured cytokines in organoid culture

Reference:
1. Zhao, Z., Chen, X., Dowbaj, A. M. et al. Organoids. Nature Reviews Methods Primers 2, 94 (2022). doi:10.1038/s43586-022-00174-y.
2. Clevers, H. Modeling Development and Disease with Organoids. Cell 165, 1586–1597 (2016). doi: 10.1016/j.cell.2016.05.082.
3. Hendriks, D., Artegiani, B., Margaritis, T. et al. Mapping of mitogen and metabolic sensitivity in organoids defines requirements for human hepatocyte growth. Nature Communications 15, 4034 (2024). doi:10.1038/s41467-024-48550-4.
4. Wu, H., Liu, S., Chen, S. et al. Generation of proliferative hESC-derived grape-clustered hepatocyte organoids with multipolar architecture as regenerative counterpart via synergy of YAP and IGF2 pathways. Cell Death & Disease 17, 381 (2026). doi:10.1038/s41419-026-08635-y.
5. Sato, T., Vries, R. G., Snippert, H. J. et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459, 262–265 (2009). doi:10.1038/nature07935.
6. Sato, T., Stange, D. E., Ferrante, M. et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett’s epithelium. Gastroenterology 141, 1762–1772 (2011). doi: 10.1053/j.gastro.2011.07.050.
7. Xu, M., Kong, D., Sun, S. et al. Organoids for disease modeling and treatment: state-of-the-art. Experimental Hematology & Oncology 15, 10 (2026). doi:10.1186/s40164-026-00743-x.
8. Tang, X.-Y., Wu, S., Wang, D. et al. Human organoids in basic research and clinical applications. Signal Transduction and Targeted Therapy 7, 168 (2022). doi:10.1038/s41392-022-01024-9.
9. Thorel, L., Perréard, M., Florent, R. et al. Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology. Experimental & Molecular Medicine 56, 1531–1551 (2024). doi:10.1038/s12276-024-01272-5.
10. Wensink, G. E., Elias, S. G., Mullenders, J. et al. Patient-derived organoids as a predictive biomarker for treatment response in cancer patients. npj Precision Oncology 5, 30 (2021). doi:10.1038/s41698-021-00168-1.
11. Jin, Y., Park, S. & Cho, S.-W. Organoid analytical toolkits. Nature Reviews Bioengineering 4, 336–352 (2026). doi:10.1038/s44222-025-00384-5.

Sponsored content is written and provided to BioSpace by the advertiser. It is published with the advertiser’s approval without contribution from BioSpace’s editorial and insights teams.